Literature DB >> 11858920

Potential drug-drug interactions in elderly patients presenting with syncope.

Theodore J Gaeta1, Melissa Fiorini, Kimberly Ender, Joseph Bove, Jose Diaz.   

Abstract

Adverse drug reactions and interactions are a common cause of iatrogenic disease. Although there are resources available that have been developed for assessing potential drug-drug interactions (DDIs), one must first consider the possibility in order to apply these tools. This cross-sectional analysis of elderly patients evaluates Emergency Physician documentation of potential DDIs and assesses the utility of computer software recognition of interactions that can lead to syncope. In this study, lack of documentation of a patient's past medical history and medications suggests that Emergency Physicians are not evaluating DDIs as a possible source of their patient's symptoms. The computer resources evaluated were found to be easy to use and reliable. Rectifying and preventing potential DDIs can be an indispensible service provided by the Emergency Physician.

Entities:  

Mesh:

Year:  2002        PMID: 11858920     DOI: 10.1016/s0736-4679(01)00471-1

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  8 in total

Review 1.  Syncope in the Elderly.

Authors:  Helen O' Brien; Rose Anne Kenny
Journal:  Eur Cardiol       Date:  2014-07

2.  Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.

Authors:  Silvia-Regina Secoli; Albert Figueras; Maria Lúcia Lebrão; Fernão Dias de Lima; Jair Licio Ferreira Santos
Journal:  Drugs Aging       Date:  2010-09-01       Impact factor: 3.923

3.  Adverse drug reactions in special populations - the elderly.

Authors:  E A Davies; M S O'Mahony
Journal:  Br J Clin Pharmacol       Date:  2015-05-22       Impact factor: 4.335

4.  Patterns and characteristics of polypharmacy among elderly residents in Danish nursing homes.

Authors:  Jacob Astorp; Mimoza Gjela; Pernille Jensen; Rasmus D Bak; Parisa Gazerani
Journal:  Future Sci OA       Date:  2020-05-29

Review 5.  Prevalence of drug interactions in hospital healthcare.

Authors:  María Espinosa-Bosch; Bernardo Santos-Ramos; María Victoria Gil-Navarro; María Dolores Santos-Rubio; Roberto Marín-Gil; Paloma Villacorta-Linaza
Journal:  Int J Clin Pharm       Date:  2012-09-11

6.  Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study.

Authors:  Nikica Mirosevic Skvrce; Viola Macolic Sarinic; Iva Mucalo; Darko Krnic; Nada Bozina; Sinisa Tomic
Journal:  Croat Med J       Date:  2011-10-15       Impact factor: 1.351

7.  Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital, North West Ethiopia.

Authors:  Endalkachew Admassie; Tesfahun Melese; Woldeselassie Mequanent; Wubshet Hailu; B Akshaya Srikanth
Journal:  J Adv Pharm Technol Res       Date:  2013-10

8.  Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy.

Authors:  Paula Bachmann; Niklas Frahm; Jane Louisa Debus; Pegah Mashhadiakbar; Silvan Elias Langhorst; Barbara Streckenbach; Julia Baldt; Felicita Heidler; Michael Hecker; Uwe Klaus Zettl
Journal:  Pharmaceutics       Date:  2022-03-08       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.